Allozymes has developed a proprietary ultra-high throughput microfluidics platform for the engineering of enzymes and microbes which enables the rapid and cost-effective development of biomanufactured ingredients and bioprocesses.

“By combining Allozymes technological capabilities with Syensqo's application and market access expertise, we are poised to create groundbreaking solutions that will not only benefit the home and personal care market but also contribute to a more sustainable future,” said Thomas Canova, head of Renewable Materials & Biotechnology growth platform at Syensqo.

Syensqo said that this MoU marks an important milestone in its strategic agenda of rapidly expanding its beauty specialty ingredients portfolio based on biotechnology and complements the company's recent acquisition of South Korean ceramides specialist JinYoung Bio.

“Our partnership with Syensqo embodies our mutual commitment to a sustainable future, leveraging biotechnology to enable cleaner, greener processes, ensuring our actions today contribute to a healthier planet for future generations. Together, we're setting a new standard for environmental stewardship," commented Peyman Salehian, CEO and co-founder at Allozymes.